|
|
|
Insider
Information: |
Plunkett Matthew |
Relationship: |
Officer |
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
563,709 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,783,249 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
563,709 |
|
|
Total
Value |
$4,783,249 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Chief Business Of... |
2016-03-21 |
526,210 |
2012-10-16 |
0 |
Premium* |
|
Nkarta, Inc. |
NKTX |
Officer |
2020-07-09 |
37,499 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-03-21 |
4 |
S |
$3.71 |
$633,384 |
D/D |
(170,000) |
620,904 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-06-04 |
4 |
AS |
$2.97 |
$36,256 |
D/D |
(12,000) |
596,904 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-05-05 |
4 |
AS |
$2.93 |
$35,497 |
D/D |
(12,000) |
608,904 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-07-07 |
4 |
AS |
$2.82 |
$34,699 |
D/D |
(12,000) |
584,904 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-09-23 |
4 |
AS |
$2.50 |
$131,358 |
D/D |
(51,818) |
441,968 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-09-22 |
4 |
AS |
$2.49 |
$133,560 |
D/D |
(51,817) |
493,786 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-09-04 |
4 |
AS |
$2.47 |
$67,617 |
D/D |
(27,301) |
545,603 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-08-04 |
4 |
AS |
$2.45 |
$29,722 |
D/D |
(12,000) |
572,904 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-03-04 |
4 |
AS |
$2.39 |
$28,939 |
D/D |
(12,000) |
847,223 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-10-06 |
4 |
AS |
$2.38 |
$28,733 |
D/D |
(12,000) |
429,968 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-11-04 |
4 |
AS |
$2.37 |
$28,665 |
D/D |
(12,000) |
417,968 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-01-05 |
4 |
AS |
$2.34 |
$28,365 |
D/D |
(12,000) |
393,968 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2014-12-04 |
4 |
AS |
$2.22 |
$26,808 |
D/D |
(12,000) |
405,968 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-02-04 |
4 |
AS |
$2.20 |
$26,651 |
D/D |
(12,000) |
859,223 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-06-04 |
4 |
AS |
$2.05 |
$20,613 |
D/D |
(10,000) |
691,740 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-03-23 |
4 |
AS |
$1.95 |
$116,029 |
D/D |
(59,130) |
728,309 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-03-21 |
4 |
D |
$1.94 |
$115,682 |
D/D |
(59,784) |
787,439 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-07-06 |
4 |
AS |
$1.92 |
$19,493 |
D/D |
(10,000) |
681,740 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-04-06 |
4 |
AS |
$1.86 |
$31,182 |
D/D |
(16,569) |
711,740 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-05-04 |
4 |
AS |
$1.85 |
$18,553 |
D/D |
(10,000) |
701,740 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-08-04 |
4 |
AS |
$1.84 |
$18,426 |
D/D |
(10,000) |
671,740 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-09-04 |
4 |
AS |
$1.53 |
$15,355 |
D/D |
(10,000) |
649,214 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-09-04 |
4 |
D |
$1.52 |
$19,040 |
D/D |
(12,526) |
659,214 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-09-24 |
4 |
AS |
$1.52 |
$119,041 |
D/D |
(75,869) |
725,084 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Development |
|
2015-10-05 |
4 |
AS |
$1.52 |
$15,204 |
D/D |
(10,000) |
640,084 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|